Best Sustainable Biotech Company 2022

HBC is proud to be Global Health & Pharma’s Best Sustainable Biotech Company 2022, recognising 15 years of pioneering research and healthcare innovations.
OMV Award WEB

Ground-breaking research and dedication to zero-waste salmon production has seen HBC named Best Sustainable Biotech Company 2022 at the Global Health & Pharma Biotechnology Awards.

A global leader in marine lipid and peptide research, HBC uses patent-protected hydrolysis technology to convert fresh sashimi-grade salmon byproducts into nutritional ingredients to support human health. Through this gentle enzymatic hydrolysis process, HBC preserves the quality of the lipids, proteins, lipo-proteins and calcium/collagen from fresh salmon off-cuts to produce three ingredients: ProGo® bioactive peptides, CalGo® calcium collagen complex, and OmeGo® full spectrum omegas. Thanks to their unique antioxidant and anti-inflammatory properties, these ingredients have earned clinically-proven, never-before-seen health claims and US FDA, Health Canada and EFSA approval.

“We’re proud to see our sustainable approach to research, technology and human nutrition recognised through these prestigious awards,” comments Dr Crawford Currie, Head of Medical R&D at HBC. “We look forward to the future, as we continue to build on our core values of sustainability, optimal utilization of natural resources and full traceability.”